Update in Pediatric Rheumatology
There have been exciting advances in the recognition, diagnosis and management of autoimmune and autoinflammatory conditions. The focus of this chapter will be an update on the assessment of pediatric musculoskeletal (MSK) complaints for the general practitioner, the diagnosis and management of juvenile idiopathic arthritis (JIA), non-inflammatory MSK causes of pain, macrophage activation syndrome and a review of the most common autoinflammatory diseases (periodic fever syndromes).
- Bleesing J, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:965–71. https://doi.org/10.1002/art.22416.CrossRefPubMedGoogle Scholar
- Petty R, Laxer R, Lindsey C, Wedderburn L. Textbook of pediatric rheumatology. 7th ed. Amsterdam: Elsevier; 2016.Google Scholar
- Ravelli A, et al. Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaboration. Arthritis Rheum. 2016;68(3):566–76.Google Scholar
- Smith N, et al. Paediatric musculoskeletal matters (pmm)—collaborative development of an online evidence based interactive learning tool and information resource for education in paediatric musculoskeletal medicine. Pediatr Rheumatol Online J. 2016;14:1. https://doi.org/10.1186/s12969-015-0062-4.CrossRefPubMedPubMedCentralGoogle Scholar